Radiation dose responses for chemoradiation therapy of pancreatic cancer: An analysis of compiled clinical data using biophysical models

2010 Kleeff, 2007, Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies, Eur J Surg Oncol, 33, 817, 10.1016/j.ejso.2007.01.022 Sener, 1999, Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the national cancer database, J Am Coll Surg, 189, 1, 10.1016/S1072-7515(99)00075-7 Yeo, 2002, Pancreatic cancer, Curr Probl Cancer, 26, 176, 10.1067/mcn.2002.129579 Sultana, 2007, Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy, Br J Cancer, 96, 1183, 10.1038/sj.bjc.6603719 Andrén-Sandberg, 2011, Pancreatic cancer: chemotherapy and radiotherapy, N Am J Med Sci, 3, 1, 10.4297/najms.2011.31 Willett, 2005, Fernandez Del Castillo C, Shih HA. Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer, Ann Surg, 241, 295, 10.1097/01.sla.0000152016.40331.bb Chang, 2009, Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas, Cancer, 115, 665, 10.1002/cncr.24059 Li, 2006, Technical and dosimetric aspects of respiratory gating using a pressure-sensor motion monitoring system, Med Phys, 33, 146, 10.1118/1.2147743 Ahunbay, 2008, An on-line replanning scheme for interfractional variations, Med Phys, 35, 3607, 10.1118/1.2952443 Li, 2011, Development of an online adaptive solution to account for inter- and intra-fractional variations, Radiother Oncol, 100, 370, 10.1016/j.radonc.2011.08.027 Ishii, 1997, Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma, Cancer, 79, 1516, 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0 Ceha, 2000, Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma, Cancer, 89, 2222, 10.1002/1097-0142(20001201)89:11<2222::AID-CNCR10>3.0.CO;2-V Andre, 2000, Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study, Int J Radiat Oncol Biol Phys, 46, 903, 10.1016/S0360-3016(99)00478-2 Boz, 2001, Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma, Int J Radiat Oncol Biol Phys, 51, 736, 10.1016/S0360-3016(01)01708-4 Wolff, 2001, Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma, Clin Cancer Res, 7, 2246 Safran, 2001, Paclitaxel and concurrent radiation for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 49, 1275, 10.1016/S0360-3016(00)01527-3 Epelbaum, 2002, Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer, J Surg Oncol, 81, 138, 10.1002/jso.10159 Ashamalla, 2003, Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer, Int J Radiat Oncol Biol Phys, 55, 679, 10.1016/S0360-3016(02)03791-4 Okusaka, 2004, Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer, Br J Cancer, 91, 673, 10.1038/sj.bjc.6602001 Morganti, 2004, 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study, Int J Radiat Oncol Biol Phys, 59, 1454, 10.1016/j.ijrobp.2004.01.035 Cohen, 2005, A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern cooperative oncology group study E8282, Int J Radiat Oncol Biol Phys, 62, 1345, 10.1016/j.ijrobp.2004.12.074 Murphy, 2007, Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer, Int J Radiat Oncol Biol Phys, 68, 801, 10.1016/j.ijrobp.2006.12.053 Saif, 2007, Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: Up-regulation of thymidine phosphorylase, Cancer J, 13, 247, 10.1097/PPO.0b013e31813c12b8 Hong, 2008, Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer, Br J Cancer, 98, 881, 10.1038/sj.bjc.6604247 Crane, 2009, Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411, J Clin Oncol, 27, 4096, 10.1200/JCO.2009.21.8529 Sudo, 2011, Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer, Int J Radiol Oncol Biol Phys, 80, 119, 10.1016/j.ijrobp.2010.01.027 De Lange, 2002, Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer, Eur J Cancer, 38, 1212, 10.1016/S0959-8049(02)00076-X Mahadevan, 2010, Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer, Int J Rad Oncol Biol Phys, 78, 735, 10.1016/j.ijrobp.2009.08.046 Polistina, 2010, Unresectable locally advanced pancreatic cancer: A multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration, Ann Surg Oncol, 17, 2092, 10.1245/s10434-010-1019-y Goyal, 2012, Stereotactic body radiation therapy for nonresectable tumors of the pancreas, J Surg Res, 174, 319, 10.1016/j.jss.2011.07.044 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Nat Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 Tai, 2009, Analyzing dose response of stereotactic body radiation therapy for lung tumors with a modified linear quadratic model, Int J Radiat Oncol Biol Phys, 75, S611, 10.1016/j.ijrobp.2009.07.1397 Tai, 2008, Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation, Int J Radiat Oncol Biol Phys, 70, 900, 10.1016/j.ijrobp.2007.10.037 Jones, 2005, The potential for mathematical modeling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy, Br J Radiol, 939, 944 Lee, 1995, Biologically effective dose distribution based on the linear quadratic model and its clinical relevance, Int J Radiat Oncol Biol Phys, 33, 375, 10.1016/0360-3016(95)00162-R Cancer Research Institute at Queen's University. Toward Canadian benchmarking for waiting times for radiotherapy cancer: Synthesizing the evidence and establishing research priorities. Cancer Care and Epidemiology 2006, Report 3, Appendix 2. James, 1975, MINUIT-a system for function minimization and error analysis of the parameter errors and correlations, Comp Phys Comm, 10, 343, 10.1016/0010-4655(75)90039-9 Mathew, 1999, Survival analysis: caveats and pitfalls, Eur J Surg Oncol, 25, 321, 10.1053/ejso.1998.0650 Iacobuzio-Donaue, 2009, DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer, J Clin Oncol, 11, 1806, 10.1200/JCO.2008.17.7188 Chang, 2008, Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time?, J Panc, 9, 676 Crane, 2011, Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression, J Clin Oncol, 29, 3037, 10.1200/JCO.2010.33.8038